Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:

Free Newsletter

  Email address:

Lilly Emphasizes China in Strategic Plan

publication date: Apr 14, 2009
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.

Eli Lilly and Company will not attempt a large-scale merger similar to the ones currently in the big pharma news; instead, the company says it will continue to implement its diversified drug development model, with a healthy dose of partnerships adding to in-house R&D. One of the goals of the company is to become the fastest growing pharmaceutical company operating in China. More details...

Stock Symbol: (NYSE: LLY)

Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...